VBI Vaccines Net Worth

VBI Vaccines Net Worth Breakdown

  VBIVQ
The net worth of VBI Vaccines is the difference between its total assets and liabilities. VBI Vaccines' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of VBI Vaccines' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. VBI Vaccines' net worth can be used as a measure of its financial health and stability which can help investors to decide if VBI Vaccines is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in VBI Vaccines stock.

VBI Vaccines Net Worth Analysis

VBI Vaccines' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including VBI Vaccines' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of VBI Vaccines' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform VBI Vaccines' net worth analysis. One common approach is to calculate VBI Vaccines' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares VBI Vaccines' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing VBI Vaccines' net worth. This approach calculates the present value of VBI Vaccines' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of VBI Vaccines' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate VBI Vaccines' net worth. This involves comparing VBI Vaccines' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into VBI Vaccines' net worth relative to its peers.
To determine if VBI Vaccines is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding VBI Vaccines' net worth research are outlined below:
VBI Vaccines generated a negative expected return over the last 90 days
VBI Vaccines has high historical volatility and very poor performance
VBI Vaccines has some characteristics of a very speculative penny stock
VBI Vaccines has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 8.68 M. Net Loss for the year was (92.84 M) with profit before overhead, payroll, taxes, and interest of 0.
VBI Vaccines generates negative cash flow from operations
VBI Vaccines has a frail financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: VBI Vaccines Provides an Update on its Restructuring Proceedings and Announces Partial Revocation Order from the British Columbia Securities Commission

VBI Vaccines Quarterly Good Will

1.11 Million

VBI Vaccines time-series forecasting models is one of many VBI Vaccines' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary VBI Vaccines' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

VBI Vaccines Earnings per Share Projection vs Actual

VBI Vaccines Corporate Management

FRCPC MDChief OfficerProfile
Avi MazaltovGlobal SciVacProfile
Misha NossovSenior EuropeProfile
David AndersonChief OfficerProfile

Additional Tools for VBI Stock Analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.